QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Decentralised Procedure (DCP): How It Works

Test your understanding of the concepts covered by Decentralised Procedure (DCP): How It Works.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which statement best reflects the role of the QPPV in relation to a DCP?

The QPPV automatically owns and directs the entire DCP The QPPV has no interest in DCP outcomes because pharmacovigilance begins only after approval The QPPV oversees pharmacovigilance responsibilities and needs effective interfaces with regulatory affairs The QPPV replaces the RMS in assessing the benefit-risk balance

Question 2 of 10 Which statement best describes the role of a Concerned Member State (CMS) in the scientific assessment?

It must automatically endorse the RMS assessment It independently reviews the application and RMS assessment and may raise questions or concerns It conducts a completely separate procedure unrelated to the RMS assessment It grants the RMS a delegation of its national authorisation powers

Question 3 of 10 Which statement most accurately contrasts DCP with the centralised procedure?

DCP and the centralised procedure both culminate in a single Union marketing authorisation DCP is European only in its scientific content, whereas the centralised procedure has no scientific coordination DCP culminates in national authorisations, whereas the centralised procedure culminates in a Union marketing authorisation DCP can be used only for products that already have national authorisations

Question 4 of 10 Why should an applicant manage a DCP as one coordinated regulatory process rather than as unrelated national submissions?

Because national competent authorities have no individual responsibilities Because scientific positions, questions, responses, conclusions and implementation need to remain traceable and coherent across participants Because the applicant is prohibited from identifying national differences Because the RMS assumes all post-authorisation responsibilities for the applicant

Question 5 of 10 Which sequence most accurately represents the core DCP lifecycle described in the article?

National authorisation, validation, RMS selection, CMS review, application submission Eligibility, participating Member State and RMS selection, submission, validation, assessment, discussion, agreement and national authorisation CMS disagreement, Article 29(4) referral, centralised authorisation and national implementation in every case Centralised assessment, Union authorisation, national recognition and post-authorisation validation

Question 6 of 10 Which starting position most appropriately distinguishes a DCP from a Mutual Recognition Procedure (MRP)?

DCP uses an RMS, whereas MRP does not DCP involves product information, whereas MRP does not DCP begins without a relevant existing national marketing authorisation in the participating Member States DCP is assessed scientifically, whereas MRP is assessed only administratively

Question 7 of 10 A company wants national authorisations in three Member States, but the product is already authorised nationally in one of those states. What is the most appropriate initial regulatory conclusion?

DCP is automatically required because several Member States are involved MRP may be relevant if the existing authorisation can serve as the basis for recognition, subject to eligibility A centralised procedure is automatically required No European coordination procedure can be used

Question 8 of 10 What is the principal function of the Reference Member State (RMS) during a DCP?

To issue a legally binding Union marketing authorisation To act as the superior regulator of the CMSs To coordinate the scientific assessment and prepare core assessment documentation To replace the applicant in responding to all scientific questions

Question 9 of 10 Which description best captures the relationship between the RMS and CMSs?

The RMS is hierarchically superior to the CMSs The CMSs are private consultants appointed by the RMS The authorities coordinate under a common legal framework while remaining national competent authorities The CMSs lose their national legal identity for the duration of the procedure

Question 10 of 10 Which conclusion about post-authorisation changes is supported by the article?

Every subsequent change must follow exactly the original DCP route The original DCP has no relevance to later regulatory decisions The applicable post-authorisation mechanism depends on the nature of the change and current legislation and guidance All post-authorisation changes are handled solely by the RMS

Knowledge Assessment: Decentralised Procedure (DCP): How It Works

Cookie Settings